FDA proposes higher fees for drug approvals to cover postmarketing surveillance.
Tanne
Janice Hopkins
JH
D017277:Drug Approval / Q000191:economics*; D005249:Fees and Charges; D011358:Product Surveillance, Postmarketing / Q000191:economics*; D014481:United States; D014486:United States Food and Drug Administration